Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 21;11(4):e200248.
doi: 10.1212/NXG.0000000000200248. eCollection 2025 Aug.

Executive Function Deficits in Genetic Frontotemporal Dementia: Results From the GENFI Study

Affiliations

Executive Function Deficits in Genetic Frontotemporal Dementia: Results From the GENFI Study

Lucy Louise Russell et al. Neurol Genet. .

Abstract

Background and objectives: Executive dysfunction is a core feature of frontotemporal dementia (FTD). While there has been extensive research into such impairments in sporadic FTD, there has been little research in the familial forms.

Methods: Seven hundred fifty-two individuals were recruited in total: 214 C9orf72; 205 progranulin (GRN) and 86 microtubule associated protein tau (MAPT) mutation carriers, stratified into asymptomatic, prodromal, and fully symptomatic; and 247 mutation-negative controls. Attention and executive function were measured using the Weschler Memory Scale-Revised (WMS-R) Digit Span Backwards (DSB), Wechsler Adult Intelligence Scale-Revised Digit Symbol task, Trail Making Test Parts A and B, and the Delis-Kaplan Executive Function System Color Word Interference Test. Linear regression models with bootstrapping were used to assess differences between groups. Correlation of task score with disease severity was also performed, as well as an analysis of the neuroanatomical correlates of each task.

Results: Fully symptomatic C9orf72, GRN, and MAPT mutation carriers were significantly impaired on all tasks compared with controls (all p < 0.001), except on the WMS-R DSB in the MAPT mutation carriers (p = 0.147). While asymptomatic and prodromal C9orf72 individuals also demonstrated differences compared with controls, neither the GRN or MAPT asymptomatic or prodromal mutation carriers showed significant deficits. All tasks were significantly correlated with disease severity in each of the genetic groups (all p < 0.001).

Discussion: Some individuals with C9orf72 mutations show difficulties with executive function from very early on in the disease and this continues to deteriorate with disease severity. By contrast, similar difficulties occur only in the later stages of the disease in GRN and MAPT mutation carriers. This differential performance across the genetic groups will be important in neuropsychological task selection in upcoming clinical trials.

PubMed Disclaimer

Conflict of interest statement

The authors report no relevant disclosures. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.

Figures

Figure
Figure. Performance of Mutation Carrier Groups on Each Executive Function Task Expressed as a Z-Score to Allow Comparison Across Tasks
DSST = Wechsler Adult Intelligence Scale-Revised Digit Symbol substitution task; DSB: Weschler Memory Scale-Revised Digit Span Backwards; D-KEFS: Delis Kaplan Executive Function System (Color-Word Interference Test – Color = Color naming, Word = Word naming, Ink = Ink color naming); TMT: Trail Making Test (A = Part A; B = Part B).

References

    1. Warren JD, Rohrer JD, Rossor MN. Clinical review. frontotemporal dementia. BMJ. 2013;347:f4827. doi: 10.1136/bmj.f4827 - DOI - PMC - PubMed
    1. Woollacott IO, Rohrer JD. The clinical spectrum of sporadic and familial forms of frontotemporal dementia. J Neurochem. 2016;138(suppl 1):6-31. doi: 10.1111/jnc.13654 - DOI - PubMed
    1. LaCaille L, Patino-Fernandez AM, Monaco J, et al. Executive function. Encyclopedia Behav Med. 2013:725-727. doi: 10.1007/978-1-4419-1005-9_1126 - DOI
    1. Lulé DE, Müller HP, Finsel J, et al. Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder. J Neurol Neurosurg Psychiatry. 2020;91(11):1195-1200. doi: 10.1136/jnnp-2020-323671 - DOI - PMC - PubMed
    1. Staffaroni AM, Bajorek L, Casaletto KB, et al. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020;16(1):11-21. doi: 10.1016/j.jalz.2019.01.012 - DOI - PMC - PubMed